These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 18509671)

  • 1. Expression of the muscular dystrophy-associated caveolin-3(P104L) mutant in adult mouse skeletal muscle specifically alters the Ca(2+) channel function of the dihydropyridine receptor.
    Weiss N; Couchoux H; Legrand C; Berthier C; Allard B; Jacquemond V
    Pflugers Arch; 2008 Nov; 457(2):361-75. PubMed ID: 18509671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of caveolin-3 induced by the dystrophy-associated P104L mutation impairs L-type calcium channel function in mouse skeletal muscle cells.
    Couchoux H; Allard B; Legrand C; Jacquemond V; Berthier C
    J Physiol; 2007 May; 580(Pt.3):745-54. PubMed ID: 17317753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caveolin-3 is a direct molecular partner of the Cav1.1 subunit of the skeletal muscle L-type calcium channel.
    Couchoux H; Bichraoui H; Chouabe C; Altafaj X; Bonvallet R; Allard B; Ronjat M; Berthier C
    Int J Biochem Cell Biol; 2011 May; 43(5):713-20. PubMed ID: 21262376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The caveolin-3 P104L mutation in LGMD-1C patients inhibits non-insulin-stimulated glucose metabolism and growth but promotes myocyte proliferation.
    Shang L; Chen T; Xian J; Deng Y; Huang Y; Zhao Q; Liang G; Liang Z; Lian F; Wei H; Huang Q
    Cell Biol Int; 2019 Jun; 43(6):669-677. PubMed ID: 30958599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caveolin-3 deficiency associated with the dystrophy P104L mutation impairs skeletal muscle mitochondrial form and function.
    Shah DS; Nisr RB; Stretton C; Krasteva-Christ G; Hundal HS
    J Cachexia Sarcopenia Muscle; 2020 Jun; 11(3):838-858. PubMed ID: 32090499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Caveolin-3 P104L mutation of LGMD-1C leads to disordered glucose metabolism in muscle cells.
    Deng YF; Huang YY; Lu WS; Huang YH; Xian J; Wei HQ; Huang Q
    Biochem Biophys Res Commun; 2017 Apr; 486(2):218-223. PubMed ID: 28232187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuated Ca(2+) release in a mouse model of limb girdle muscular dystrophy 2A.
    DiFranco M; Kramerova I; Vergara JL; Spencer MJ
    Skelet Muscle; 2016; 6():11. PubMed ID: 26913171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endoplasmic reticulum stress response in P104L mutant caveolin-3 transgenic mice.
    Kuga A; Ohsawa Y; Okada T; Kanda F; Kanagawa M; Toda T; Sunada Y
    Hum Mol Genet; 2011 Aug; 20(15):2975-83. PubMed ID: 21610159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An inhibitor of transforming growth factor beta type I receptor ameliorates muscle atrophy in a mouse model of caveolin 3-deficient muscular dystrophy.
    Ohsawa Y; Okada T; Nishimatsu S; Ishizaki M; Suga T; Fujino M; Murakami T; Uchino M; Tsuchida K; Noji S; Hinohara A; Shimizu T; Shimizu K; Sunada Y
    Lab Invest; 2012 Aug; 92(8):1100-14. PubMed ID: 22584670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphofructokinase muscle-specific isoform requires caveolin-3 expression for plasma membrane recruitment and caveolar targeting: implications for the pathogenesis of caveolin-related muscle diseases.
    Sotgia F; Bonuccelli G; Minetti C; Woodman SE; Capozza F; Kemp RG; Scherer PE; Lisanti MP
    Am J Pathol; 2003 Dec; 163(6):2619-34. PubMed ID: 14633633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caveolin-3 T78M and T78K missense mutations lead to different phenotypes in vivo and in vitro.
    Traverso M; Gazzerro E; Assereto S; Sotgia F; Biancheri R; Stringara S; Giberti L; Pedemonte M; Wang X; Scapolan S; Pasquini E; Donati MA; Zara F; Lisanti MP; Bruno C; Minetti C
    Lab Invest; 2008 Mar; 88(3):275-83. PubMed ID: 18253147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caveolin-3 loss linked with the P104L LGMD-1C mutation modulates skeletal muscle mTORC1 signalling and cholesterol homeostasis.
    Shah DS; Nisr RB; Krasteva-Christ G; Hundal HS
    J Cachexia Sarcopenia Muscle; 2023 Oct; 14(5):2310-2326. PubMed ID: 37671684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations of excitation-contraction coupling and excitation coupled Ca(2+) entry in human myotubes carrying CAV3 mutations linked to rippling muscle.
    Ullrich ND; Fischer D; Kornblum C; Walter MC; Niggli E; Zorzato F; Treves S
    Hum Mutat; 2011 Mar; 32(3):309-17. PubMed ID: 21294223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caveolin-3 associates with and affects the function of hyperpolarization-activated cyclic nucleotide-gated channel 4.
    Ye B; Balijepalli RC; Foell JD; Kroboth S; Ye Q; Luo YH; Shi NQ
    Biochemistry; 2008 Nov; 47(47):12312-8. PubMed ID: 19238754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical and pathological changes result from mutated Caveolin-3 in muscle.
    González Coraspe JA; Weis J; Anderson ME; Münchberg U; Lorenz K; Buchkremer S; Carr S; Zahedi RP; Brauers E; Michels H; Sunada Y; Lochmüller H; Campbell KP; Freier E; Hathazi D; Roos A
    Skelet Muscle; 2018 Aug; 8(1):28. PubMed ID: 30153853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscular dystrophy begins early in embryonic development deriving from stem cell loss and disrupted skeletal muscle formation.
    Merrick D; Stadler LK; Larner D; Smith J
    Dis Model Mech; 2009; 2(7-8):374-88. PubMed ID: 19535499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caveolin-3 regulates myostatin signaling. Mini-review.
    Ohsawa Y; Okada T; Kuga A; Hayashi S; Murakami T; Tsuchida K; Noji S; Sunada Y
    Acta Myol; 2008 Jul; 27(1):19-24. PubMed ID: 19108573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic behavior of caveolin-3 mutations that cause autosomal dominant limb girdle muscular dystrophy (LGMD-1C). Retention of LGMD-1C caveolin-3 mutants within the golgi complex.
    Galbiati F; Volonte D; Minetti C; Chu JB; Lisanti MP
    J Biol Chem; 1999 Sep; 274(36):25632-41. PubMed ID: 10464299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long QT syndrome caveolin-3 mutations differentially modulate K
    Tyan L; Foell JD; Vincent KP; Woon MT; Mesquitta WT; Lang D; Best JM; Ackerman MJ; McCulloch AD; Glukhov AV; Balijepalli RC; Kamp TJ
    J Physiol; 2019 Mar; 597(6):1531-1551. PubMed ID: 30588629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A caveolin-3 mutant that causes limb girdle muscular dystrophy type 1C disrupts Src localization and activity and induces apoptosis in skeletal myotubes.
    Smythe GM; Eby JC; Disatnik MH; Rando TA
    J Cell Sci; 2003 Dec; 116(Pt 23):4739-49. PubMed ID: 14600260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.